Characterization of the Cord Blood Stem Cell in Situation of Neonatal Asphyxia
NEOCORD
1 other identifier
interventional
10
1 country
1
Brief Summary
Neonatal anoxic-ischaemic enkephalopathy is a dramatic perinatal complication due to brain asphyxia. Neurological and neurosensory sequelae are frequent in survivors, due to neuronal damage and loss. For the moment, only total or partial body hypothermia can partially prevent cell loss. However, no treatment exists to restore neuronal functions. Cord blood stem cells are a promising treatment for the near future. However, before conducting a clinical trial to evaluate the safety and feasibility of autologous cell therapy in neonatal asphyxia, in vitro characterization of the cord blood stem cell in situation of neonatal asphyxia, compared to normal situation, is needed. The primary objective of this study is to characterize cord blood stem cells of neonates with neonatal asphyxia and to compare them with those from healthy newborn. The quantitative and qualitative, functional characterization will insist on cell populations which could potentially participate to neuronal regeneration. Secondary objectives are to assess such characteristics in conditions of cryo-preservation, compared to fresh cell preparation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 16, 2010
CompletedFirst Posted
Study publicly available on registry
January 27, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedAugust 3, 2016
August 1, 2016
5.9 years
April 16, 2010
August 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary objective of this study is to characterize cord blood stem cells of neonates with neonatal asphyxia and to compare them with those from healthy newborn
The quantitative and qualitative, functional characterization will insist on cell populations which could potentially participate to neuronal regeneration.
two years
Interventions
The quantitative and qualitative, functional characterization will insist on cell populations which could potentially participate to neuronal regeneration. and assessment such characteristics in conditions of cryo-preservation, compared to fresh cell preparation
Eligibility Criteria
You may qualify if:
- delivery at 37 week or more of pregnancy
- normal pregnancy and delivery
You may not qualify if:
- parental refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance publique Hopitaux de Marseille
Marseille, bouches du Rhone, 13005, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Umberto SIMEONI, MD PhD
AP-HM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2010
First Posted
January 27, 2011
Study Start
April 1, 2010
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
August 3, 2016
Record last verified: 2016-08